Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 19
Original Research
Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,205 | Dovepress* | 1,130+ | 59 | 1,189 | |
| PubMed Central* | 75 | 50 | 125 | ||
| Totals | 1,205 | 109 | 1,314 | ||
| *Since 24 October 2023 | |||||
View citations on PubMed Central and Google Scholar